Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,691 | -69,897 | -57,352 | -26,441 | -7,254 |
| Depreciation Amortization | 58 | 300 | 226 | 151 | 76 |
| Accounts receivable | 17 | -102 | 131 | 114 | 131 |
| Other Working Capital | 1,406 | -1,376 | -532 | 982 | -1,504 |
| Other Operating Activity | -599 | 13,460 | 14,122 | 576 | -3,492 |
| Operating Cash Flow | $-11,809 | $-57,615 | $-43,405 | $-24,618 | $-12,043 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,108 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,498 | 58,142 | 52,380 | 14,146 | 14,006 |
| Other Financing Activity | -158 | -1,624 | -1,509 | -807 | -804 |
| Financing Cash Flow | $232 | $56,518 | $50,871 | $13,339 | $13,202 |
| Beginning Cash Position | 28,757 | 29,854 | 29,854 | 29,854 | 29,854 |
| End Cash Position | 17,180 | 28,757 | 37,320 | 18,575 | 31,013 |
| Net Cash Flow | $-11,577 | $-1,097 | $7,466 | $-11,279 | $1,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,809 | -57,615 | -43,405 | -24,618 | -12,043 |
| Free Cash Flow | -11,809 | -57,615 | -43,405 | -24,618 | -12,043 |